Nordic Life Science
menu_bg Welcome menu_sep About us menu_sep Partners menu_sep Advertising menu_sep Subscriptions menu_sep Newsletter menu_sep Careers menu_sep Contact

 

Financial markets

venture

 

 

Capital and financing are one the most important factors for facilitating product development and growth for a young life science company. As many start-ups have years of costly development ahead, they need to go hand in hand with investors for a long period before they can, hopefully, generate substantial revenues. One of the more important factors for life sciences development regions is thus a well-functioning venture capital market and the ability to attract and facilitate foreign investment.

 

Among the Nordic countries, the conditions for venture capital markets vary extensively, as well as their success in attracting foreign investors. In this section, we present companies representing the venture capital market in the Nordic countries and their views on their home markets. We also present their strategies for finding interesting objects and the effect the current crisis in the banking system has had on their business.

 

 

Related articles:

 

Karo Bio - the risk is too high

 

Promising Hepatitis drug may lift Medivir during the fall

 

Top three tiers - Q1 2010

 

Business deal of the quarter Q1 2010:

Medivir closes license agreement with Meda

 

Business deal of the quarter Q4 2009:

Biovitrum Swedish Orphan creates a strong platform for a new Swedish speciality pharma

 

Business deal of the quarter Q3 2009:

Orexo strikes deal with Novartis

 

Biobusiness: What's going on in the life science market?

 

Business deal of the quarter Q2 2009:

Q-Med closes deal with Oceana Therapeutics

 

Biobusiness: The Nordic Pharma Industry

 

Business deal of the quarter Q1 2009:

The financial crisis has not affected Getinge's appetite

 

Danish venture capitalists increase investments in the midst of the credit crunch

 

What makes the Nordic countries attractive to a venture capitalist?

 

 

banner_diaservice

 

webbanner-nordic-life-science-review-q2

 

comactiva_hemsidan_image002

 

proffice28211_banner_lifescience_nordiclifescience_eks1

 

eurobanner230

 

nordic_life_s_230_170

 

 

nordiclifesciencefebrapril230x170

 

 

neurotar_animgif_banner

 

acandia_gif

 

banner_aircontainer

 

 

irw_230x170

 

 

 

banner_nordiclifescience_tfs

 

banner-02_animation_opacity_pharmacosmos